|
| Respiratory tract (n = 136) | No respiratory tract (n = 25) | p value |
| Gender |
|
|
|
| Male | 90 | 12 | 0.08 |
| Female | 46 | 13 |
|
| Age |
|
|
|
| 0 - 1 | 6 | 2 | 0.80 |
| 1 - 18 | 122 | 9 | <0.01 |
| 19 - 64 | 5 | 12 | <0.01 |
| 65- | 3 | 2 | 0.36 |
| Season |
|
|
|
| Spring | 42 | 7 | 0.77 |
| Summer | 31 | 8 | 0.32 |
| Fall | 28 | 4 | 0.80 |
| Winter | 35 | 6 | 0.85 |
| Antomicrobial susceptibility |
|
|
|
| Minocycline susceptible | 111 | 21 | 1.00 |
| Minocycline no susceptible | 25 | 4 |
|
| Clarithromycin susceptible | 45 | 17 | <0.01 |
| Clarithromycin no susceptible | 91 | 8 |
|
| Clindamycin susceptible | 98 | 21 | 0.32 |
| Clindamycin no susceptible | 38 | 4 |
|
| Ciprofloxacin susceptible | 90 | 16 | 0.83 |
| Ciprofloxacin no susceptible | 46 | 9 |
|